Downloads

Octet Systems Brochure



Company website

ForteBio



You might also be interested in:

LI-COR Odyssey

ForteBio

Label-free, Real-time Biomolecular Analysis

Proteins • Peptides • Small Molecules


Octet Instrument Platform

Fortebio's Octet platform provides instruments, biosensors, reagents and assay kits for analyzing biomolecular interactions in 96- and 384-well microplate formats. The Octet systems utilize proprietary BioLayer Interferometry (BLI) to enable real-time, label-free analysis of biomolecular interactions and to provide information on affinity, kinetics and concentration. Their analytical capabilities enable significantly easier, faster and better characterization of drug candidates, providing great value in drug development applications where existing methods have limitations in throughput, performance and cost.

KEY BENEFITS

Label-Free, Real-Time Results

Our proprietary BioLayer Interferometry (BLI) technology monitors the binding of proteins and other biomolecules to their partners directly in real time. The binding interaction is continuously monitored by measuring the change in thickness of the protein layer on the biosensor tip. The method has no need to label the protein with fluorescent or chromogenic tags, thus eliminating interference issues.

Higher Throughput

Octet systems perform analysis of samples in 96- and 384-well microplates, processing up to 16 wells in parallel. Protein quantitation can be performed on 96 samples in 20 minutes and on 384 samples in 75 minutes - compared to traditional ELISAs, which can take from 4 hours to overnight. Octet instruments accomodate one or two microplates on deck, depending on the model. Additional features in the 384-series models such as the ability to re-rack and reuse biosensors keep your workflow speeding along.

High Quality Data at an Affordable Price

The Octet systems provide fully comparable data for label-free protein interaction analysis yet cost a mere fraction of equivalent SPR systems. Reduced sample preparation and smaller samples (80 µL - 120 µL/well in 384-well plates) combined with virtually maintenance-free instrumentation greatly reduces equipment and reagent costs. Disposable biosensors with optional regeneration capability lower assay cost per well even further.

Crude Sample Compatibility

BLI technology allows sensitive detection of biomolecules binding to the biosensor surface while minimizing intereference from extraneous materials present in solution. Only molecules that bind to or dissociate from the biosensor surface produce a signal change. Proteins can be assayed in crude mixtures (cell lysates or hybridoma supernatants) or in DMSO (up to 10%), thus drastically reducing sample preparation.

Dedicated Data Acquisition and Analysis Software

All systems are supported by ForteBio's proprietary Octet data acquisition and analysis software. The data acquisition software contains quantitation, advanced quantitation and kinetics modules with dedicated methods to fully support each application. The data analysis software is highly versatile, specifically including a 2:1 heterogeneous ligand binding model, data tracking, and processing capabilities that assist in high-throughput screening. All Octet software includes optional 21 CFR Part 11 compliance tools.


5 MODELS TO CHOOSE FROM: OCTET RED384, RED, QK384, QKe, and QK


Octet Models


About ForteBio

ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification or characterization of protein-protein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.

ForteBio utilizes proprietary Bio-Layer Interferometry (BLI) that enables self-calibration and measurement of molecular interactions using simple-to-use and inexpensive instrumentation. An entire analysis can be completed within minutes and does not require labeling of either probe or target. ForteBio's analytical capabilities provide greater value in applications where existing methods such as HPLC, ELISA, and surface plasmon resonance have limitations in throughput, performance, and cost.

We have noticed that your browser doesn't have Javascript enabled. Our form system requires it to be enabled. Please click here for instructions on how to enable Javascript.